ethyl 2-(2-methoxyphenyl)ethanecarboximidate hydrochloride, 95.0%, 10g

3-Decyldihydrofuran-2,5-dione, 98%, 25g

(5R,6R)-5,6-Bis(diphenylphosphino)bicyclo[2.2.1]hept-2-ene, 98%, 100mg

Polvo de antimonio, mínimo 99,5 %, aproximadamente malla 325, 500 g, envase de plástico.

FURSULTIAMINE, 95%, 1g

VIPADENANT, 95%, 25mg

6-Butoxynaphthalene-2-boronic acid, 98%, 5g

Recipiente de cristalización ROTILABO® con pico, 2000 ml, 190 mm, 1 Pieza

Tetrabutylammonium iodide, 98.0%, 1kg

6-phenyl-3-sulfanylidene-2,3,4,5-tetrahydro-1,2,4-triazin-5-one, 98%, 1g

5-(2-HYDROXYETHYL)-3-PHENYL ISOXAZOLE, 95.0%, 500mg

4-Ethylbenzyl chloride (stabilised with calcium carbonate), 98.0%, 5g

Bis((S)-4-phenyl-4,5-dihydrooxazol-2-yl)methane, 95.0%, 250mg